SCHEMBL24372556

SCHEMBL24372556

O=C(CS)OCCCc1ccc(N(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 2/20 0.47
TDP1 Q9NUW8 1/20 0.45
FFAR1 O14842 2/20 0.44
NPC1 O15118 1/20 0.44
RECQL P46063 1/20 0.44
RAB9A P51151 1/20 0.44
CTDSP1 Q9GZU7 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
APOBEC3A P31941 2/20 0.43
APOBEC3G Q9HC16 2/20 0.43
MAPT P10636 1/20 0.43
CYP2D6 P10635 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24373015 0.94 FFAR1 (0.45) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL24372552 0.93 LMNA (0.46) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL24372731 0.88 MGLL (0.46) FFAR1
SCHEMBL24372734 0.84 LMNA (0.53) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL162267 0.82 LMNA (0.51) LMNASMN1; SMN2ALDH1A1FFAR1NPC1
SCHEMBL14063399 0.82 LMNA (0.51) LMNASMN1; SMN2ALDH1A1FFAR1NPC1
SCHEMBL24372729 0.82 ALDH1A1 (0.50) LMNAALDH1A1TDP1MEN1POLB
SCHEMBL4457866 0.80 TDP1 (0.56) LMNASMN1; SMN2ALDH1A1TDP1FFAR1
SCHEMBL279299 0.80 LMNA (0.49) LMNASMN1; SMN2NPC1RECQLRAB9A
SCHEMBL18333495 0.79 THRB (0.52) LMNASMN1; SMN2ALDH1A1FFAR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS MERCK PATENT GMBH (DE) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127286-A1 LIGANDS FOR NANO-SIZED MATERIALS L1CAM, EPCAM, SELPLG LMNA 1891/4885SMN1; SMN2 4648/4885ALDH1A1 3030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.